U.S. Interactive Media and Services Stock News

Crocs (CROX) has quietly staged a comeback, with shares up roughly 25% over the past month and about 14% in the past 3 months, despite flat revenue and volatile long term returns. See our latest analysis for Crocs. Zooming out, that strong 1 month share price return contrasts with a negative year to date share price return and a weak 1 year total shareholder return, hinting that sentiment may be turning after a choppy stretch. If Crocs has you rethinking where growth might show up next in...

Occidental Petroleum (OXY) has been grinding lower, with the stock down about 9% over the past month and roughly 18% over the past 3 months, inviting a closer look at valuation and expectations. See our latest analysis for Occidental Petroleum. That slide comes after a choppy year, where the share price has delivered a weak year to date return and a negative one year total shareholder return. This suggests momentum has faded as the market reassesses energy price risks and Occidental...

Invitation Homes (INVH) just gave income focused investors something new to consider with a 3.4% increase in its quarterly dividend, along with stronger than expected revenue and higher 2025 cash flow guidance. See our latest analysis for Invitation Homes. Those stronger fundamentals have not yet translated into the share price, with a year to date share price return of negative 14.6 percent and a one year total shareholder return of negative 14.1 percent. This suggests momentum has been...

Philip Morris International (PM) has quietly turned into one of 2024’s steadier compounders, with the stock up around 30% over the past year as investors warm to its smoke free transition story. See our latest analysis for Philip Morris International. That steady grind higher has come as the market leans into Philip Morris International’s smoke free and wellness push. The latest $157.95 share price sits on the back of a roughly 30 percent year to date share price return and a 5 year total...

Cytokinetics (CYTK) just cleared two big regulatory hurdles for its heart drug MYQORZO, with full approval in China and a positive EU opinion, and that one-two punch is reshaping how investors view its pipeline. See our latest analysis for Cytokinetics. The stock has been choppy in the short term, with a 1 month share price return of minus 6.7 percent. However, a 90 day share price return above 30 percent and a 1 year total shareholder return just under 30 percent suggest momentum is still...

If you are wondering whether Centene is a beaten down bargain or a value trap at current prices, this article will walk through what the numbers are really saying about the stock. Despite being down 35.6% year to date and 32.6% over the past year, the share price has shown some recent stability, with a 2.3% gain over the last week and 7.1% over the last month. Much of the recent price action has been shaped by shifting expectations around US healthcare policy and Medicaid redeterminations,...

If you are wondering whether KLA is still a smart buy after its huge run, or if the easy money has already been made, you are not alone. That is exactly what we will unpack here. Despite a slight dip of 0.2% over the last week, KLA is up 7.9% over the past month, 92.2% year to date, and 401.2% over five years. This naturally raises questions about how much upside may still be available. Much of this momentum has been driven by investors crowding into semiconductor and AI related names, with...

Wondering if Sea is still a smart buy after its roller coaster ride over the years, or if the easy money has already been made? The stock is up 18.5% year to date and 7.3% over the last year, but that comes after a sharp 38.1% drop over five years and a recent pullback of 11.8% in the last month. Investors have been reacting to shifts in Sea's core businesses, from its expanding digital financial services arm in Southeast Asia to ongoing efforts to stabilize growth in its e commerce and...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The board of The Toro Company ( NYSE:TTC ) has announced that it will be paying its dividend of $0.39 on the 12th of...

Some CME Group Inc. ( NASDAQ:CME ) shareholders may be a little concerned to see that the Chairman & CEO, Terrence...

Some The Carlyle Group Inc. ( NASDAQ:CG ) shareholders may be a little concerned to see that the Co-Founder...

Synopsys (SNPS) just got a confidence boost after Bank of America shifted to a more positive stance, citing strong Q4 revenue growth, successful Ansys integration, and healthier exposure to China and Intel. See our latest analysis for Synopsys. That upgrade lands after a volatile stretch where the share price slid earlier in the year but has recently regained momentum, with a 1 month share price return of 18.86 percent and a 3 year total shareholder return of 42.82 percent, still underscoring...

Rezolve AI stock reaction to recent performance Rezolve AI (RZLV) has experienced a choppy ride, with the share price up slightly over the past month but still down sharply over the past 3 months and year to date. See our latest analysis for Rezolve AI. The recent 1 day share price return of 28.02 percent has given RZLV a jolt of positive momentum, but that sits against a much weaker 3 year total shareholder return of negative 70.48 percent, so sentiment is still in repair mode at a share...

Northwest Bancshares (NWBI) has quietly outperformed many regional peers over the past month, gaining about 8% while still sitting on a modest loss year to date. This makes the recent move worth unpacking. See our latest analysis for Northwest Bancshares. That recent 8% one month share price return has started to reverse some of Northwest Bancshares year to date weakness, and with the 5 year total shareholder return above 40%, the current 12.71 dollar share price suggests momentum is quietly...

MP Materials (MP) has quietly staged a sharp rebound this year, even as the stock has slid over the past month and past 3 months, leaving investors debating whether this pullback offers value. See our latest analysis for MP Materials. That pullback sits against a powerful backdrop, with the share price up sharply on a year to date basis and the one year total shareholder return near 191 percent, suggesting long term momentum is still intact even as short term sentiment cools. If MP’s rare...

Wondering if monday.com is starting to look like a bargain after its slide, or if the market is signaling deeper concerns about the business. The stock is down 7.6% over the last week, 6.5% over the past month, and a steep 35.0% year to date, extending a 40.4% drop over the last year despite still being up 29.5% over three years. Much of this volatility has been driven by shifting sentiment toward high growth software names as interest rate expectations change, with investors rotating in and...

HCI Group recently reported that its core homeowners insurance operations have grown rapidly over the past two years, with net premiums earned rising about 28% annually as it applies proprietary technology to underwriting and claims. Analysts now expect book value per share to increase by about 36.9% over the coming 12 months, highlighting how HCI’s capital generation and balance sheet strength are being reinforced by this operating momentum. We’ll now consider how this acceleration in net...

Morgan Stanley previously downgraded HCA Healthcare from Equalweight to Underweight, and HCA later announced a senior notes offering to help refinance borrowings and support general corporate needs. A large institutional holder, L1 Capital International Fund, has also reduced its position after strong share price appreciation, signalling a reassessment of risk‑reward at current levels. Next, we’ll examine how concerns about potentially easing government healthcare tailwinds could reshape HCA...

Robinhood Markets (HOOD) has quietly turned into a long term winner, with the stock up about 203% this year and roughly 187% over the past year, far outpacing broader markets. See our latest analysis for Robinhood Markets. That strength has come despite some choppy weeks, with a recent pullback and rebound leaving the latest share price at $119.40 and the 1 year total shareholder return still signaling powerful, ongoing momentum rather than a one off spike. If Robinhood’s surge has you...

If you are wondering whether Symbotic is still worth considering after its huge run, or if you are late to the party, this breakdown will help you figure out what the current price is really asking you to believe. The stock has climbed about 0.8% over the last week and 7.8% over the last month, but the real eye catchers are its 153.7% year to date and 145.6% 1 year returns, on top of a 408.8% gain over 3 years. Recent headlines have focused on Symbotic's expanding automation partnerships and...

Wondering if Hecla Mining is still a bargain after its huge run, or if you are turning up late to the party? This breakdown will help you make sense of what the current share price really implies. The stock has surged recently, climbing 11.9% over the last week, 30.3% over the past month, and an eye catching 261.6% year to date. This has completely changed how the market is thinking about its risk and reward profile. That kind of move has been underpinned by a stronger silver price backdrop...

If you are wondering whether Vistra is still a smart buy after its huge run, or if the stock has already done the heavy lifting for you, this article will walk through what the numbers are really saying about its value today. Vistra's share price has climbed 5.2% over the last week and is up 15.9% year to date, capping a massive 659.4% gain over 3 years and 962.3% over 5 years that has certainly reset market expectations. Those moves have come as investors have refocused on the strategic...

Market context and recent performance SLB (SLB) has been drifting lower in the past week, but shares are still modestly higher over the past 3 months, leaving investors weighing whether this pullback offers a reasonable reentry point. See our latest analysis for SLB. The slide in the latest 1 day share price return and softer year to date share price performance sit against a much stronger 5 year total shareholder return. This suggests long term holders have still been rewarded even as near...